| CTRI Number |
CTRI/2025/10/095722 [Registered on: 08/10/2025] Trial Registered Prospectively |
| Last Modified On: |
06/10/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Calculating minimum effective dose of local anaesthetic mixture for arm surgeries using nerve block |
|
Scientific Title of Study
|
Minimum effective volume of 0.5 percent Ropivacaine and 2 percent Lignocaine mixture for ultrasound guided Retroclavicular Brachial Plexus Block: A Prospective Dose Finding Study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Heena Garg |
| Designation |
Assistant Professor |
| Affiliation |
AIIMS, New Delhi |
| Address |
Department of Anaesthesiology, AIIMS, Ansari nagar, New Delhi 110029
South DELHI 110029 India |
| Phone |
9464533877 |
| Fax |
|
| Email |
gargheena11@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Heena Garg |
| Designation |
Assistant Professor |
| Affiliation |
AIIMS, New Delhi |
| Address |
Department of Anaesthesiology, AIIMS, Ansari nagar, New Delhi 110029
DELHI 110029 India |
| Phone |
9464533877 |
| Fax |
|
| Email |
gargheena11@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Heena Garg |
| Designation |
Assistant Professor |
| Affiliation |
AIIMS, New Delhi |
| Address |
Department of Anaesthesiology, AIIMS, Ansari nagar, New Delhi 110029
DELHI 110029 India |
| Phone |
9464533877 |
| Fax |
|
| Email |
gargheena11@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of Anaesthesiology, AIIMS, Ansari nagar, New Delhi 110029 |
|
|
Primary Sponsor
|
| Name |
AIIMS New Delhi |
| Address |
Department of Anaesthesiology, AIIMS, Ansari nagar, New Delhi 110029 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| heena garg |
AIIMS |
Department of Anaesthesiology, AIIMS, Ansari nagar, New Delhi 110029 South DELHI |
9464533877
gargheena11@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institute ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
NIL |
NIL |
| Intervention |
Ropivacaine and Lignocaine mixture |
0.5% Ropivacaine and 2% Lignocaine mixture in 3:2 ratio given at the time of block after taking the patient in the operation theatre. around 24 hours in the perioperative period |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
ASA Physical Status I or II, Consent for regional anaesthesia and participation, Elective surgery of the upper limb, BMI between 18–30 kg/m²
|
|
| ExclusionCriteria |
| Details |
coagulopathy, allergy to local anaesthetics, pregnancy, pre existing neuropathy |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Participant, Investigator and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| The calculation of minimum effective volume (MEV50 and MEV95) of a mixture of 0.5% ropivacaine and 2% lignocaine for achieving a successful sensory and motor block at 30 minutes. |
The calculation of minimum effective volume (MEV50 and MEV95) of a mixture of 0.5% ropivacaine and 2% lignocaine for achieving a successful sensory and motor block at 30 minutes. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Block performance time (time from the first insertion of the blocking needle to its removal)
2. Block onset time ( time required for a composite score of 14 points)
3. Duration of sensory (time from the injection of LA to the time the patient recovers full sensation of the upper limb)
4. Duration of motor blockade (time from injection of LA to the time the patient recovers full function of the arm)
5. Any perioperative complications (e.g., local anesthetic systemic toxicity, vascular puncture)
6. Need for conversion to GA
|
from start of anaesthesia till 24 hours postoperatively |
|
|
Target Sample Size
|
Total Sample Size="25" Sample Size from India="25"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
18/10/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Combining faster onset lignocaine with other slower onset agents such as bupivacaine, levobupivacaine and ropivacaine can hasten the onset of the block. The minimum effective volume (MEV) and concentration of local anesthetics are key to maximizing the quality and safety of nerve blocks while minimizing risks such as local anesthetic systemic toxicity. Dose finding studies have been done using 0.5% bupivacaine and 0.5% ropivacaine in Retroclavicular Block (RCB). A clinically effective dose of combination of local anaesthetic (LA) for achieving an adequate block with retroclavicular approach is lacking. This study seeks to determine the MEV50 and MEV95 of a 3:2 mixture of 0.5% ropivacaine and 2% lignocaine in adults undergoing upper limb surgeries under the retroclavicular approach of infraclavicular block. |